[PDF][PDF] Clinical effectiveness of decitabine in severe sickle cell disease
Y Saunthararajah, R Molokie, S Saraf… - British journal of …, 2008 - academia.edu
Y Saunthararajah, R Molokie, S Saraf, S Sidhwani, M Gowhari, S Vara, D Lavelle…
British journal of haematology, 2008•academia.eduClinical effectiveness of decitabine in severe sickle cell disease Page 1 demonstrated in AITL
samples, these may not actually be the precursors to the subsequent DLBCLs these patients
develop. Several clonal B-cell populations may develop during the course of the disease, and
these may be transient, with many disappearing subsequently. Hence, when a proportion of
AITL patients subsequently develop a full-blown DLBCL or EBVcHL, one may or may not be
able to establish clonal ancestry to ‘precursor’ cells seen in an earlier biopsy. KN Naresh1 LP …
samples, these may not actually be the precursors to the subsequent DLBCLs these patients
develop. Several clonal B-cell populations may develop during the course of the disease, and
these may be transient, with many disappearing subsequently. Hence, when a proportion of
AITL patients subsequently develop a full-blown DLBCL or EBVcHL, one may or may not be
able to establish clonal ancestry to ‘precursor’ cells seen in an earlier biopsy. KN Naresh1 LP …
Willenbrock, K., Brauninger, A. & Hansmann, ML (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. British Journal Haematology, 138, 733–739.
academia.edu
